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To review the evidence of thromboembolism incidence and prophylaxis in the sub-acute phase of spinal cord injury (SCI) 3–6 months 
post injury. All observational and experimental studies with any length of follow-up and no limitations on language or publication 
status published up to March 2015 were included. Two review authors independently selected trials for inclusion and extracted data. 
Outcomes studied were incidence of pulmonary embolism (PE) and deep vein thrombosis (DVT) in the sub-acute phase of SCI. The 
secondary outcome was type of thromboprophylaxis. Our search identified 4305 references and seven articles that met the inclusion 
criteria. Five papers reported PE events and three papers reported DVT events in the sub-acute phase of SCI. Studies were heteroge-
neous in populations, design and outcome reporting, therefore a meta-analysis was not performed. The included studies report a PE 
incidence of 0.5%–6.0% and DVT incidence of 2.0%–8.0% in the sub-acute phase of SCI. Thromboprophylaxis was poorly reported. 
Spinal patients continue to have a significant risk of PE and DVT after the acute period of their injury. Clinicians are advised to have 
a low threshold for suspecting venous thromboembolism in the sub-acute phase of SCI and to continue prophylactic anticoagulation 
therapy for a longer period of time. 
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Introduction
Venous thromboembolism (VTE) in spinal cord in-
jury (SCI) patients has limited clinical signs. Deep vein 
thrombosis (DVT) presents frequently with leg oedema 
and fever as the only features [1]. However, this can also 
be mimicked by heterotopic ossification or cellulitis [1]. 
Blood tests including D-dimer are of limited benefit [2,3] 
and compression ultrasound is the current mainstay in 
the diagnosis for DVT. It is widely available, accurate and 
non-invasive [4]. Venography is the gold standard in di-
agnosing DVT, however is invasive, more expensive and 
involves contrast injection. It is not routinely used [4]. 
Pulmonary embolism (PE) may present with dyspnoea, 
tachycardia, syncope or chest pain. Neuropathic pain, in-
tercostal muscle paralysis and respiratory tract infections 
can have similar presentations and this contributes to the 
difficulty in diagnosing PE [1]. Diagnostic algorithms in-
cluding Wells and modified Geneva scoring systems have 
limited applicability in spinal patients [5,6]. Pulmonary 
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angiography using multidetector computed tomography 
(CTPA) is the imaging modality of choice in diagnosing 
PE [7]. 
Spinal patients have the highest risk of thromboembolic 
events amongst all hospitalized patient groups [8-11]. 
While most studies have concentrated on the incidence 
of PE and DVT in the acute phase of SCI, research on 
the sub-acute and chronic rehabilitation phases are lack-
ing [12]. Thromboprophylaxis is given in the acute phase 
based on observational evidence that PE is a significant 
cause of death in the first 90 days post injury [10,13]. 
There is no thromboprophylaxis recommended in the 
sub-acute rehabilitation phase [14]. Knowing the inci-
dence of thromboembolic events in the sub-acute reha-
bilitation phase is important to estimate risk and facilitate 
evidence based prevention in this period of injury.
 
Objective
To review the evidence of thromboembolism incidence 
and prophylaxis in the sub-acute rehabilitation of SCI.
Methods 
The protocol of this systematic review was registered in the 
international database of prospectively registered system-
atic reviews in health and social care (PROSPERO) on 29 
August 2014 (registration number: CRD42014013471) [15].
1. Eligibility Criteria for studies for this review 
1) Types of studies 
All experimental and observational studies with any 
length of follow-up were included. No limitations on 
language or publication status were applied. Case reports 
were excluded.
2) Types of participants 
We included studies of SCI at any level or mechanism 
of injury and of any age or gender. Exclusion criteria 
were studies with a follow-up finishing within the first 3 
months of injury and studies that only included patients 
more than 6 months after injury.
2. Types of outcome measures 
Studies were eligible if they reported thromboembolic 
events including DVTs or PEs in the sub-acute phase of 
SCI (3–6 months post injury).
3. Outcomes
The three outcomes were incidence of PE in the sub-acute 
phase of SCI, incidence of DVT in the sub-acute phase of 
SCI and thromboprophylaxis used in the sub-acute phase.
4. Search methods for identification of studies
The Cochrane Central Register of Controlled Trials (CEN-
TRAL, March 2015), MEDLINE (HDAS, 1950 to March 
2015) and EMBASE Classic and EMBASE (HDAS, 1980 
to March 2015) databases were searched as summarized 
by the medical librarian at Stoke Mandeville Hospital. The 
search strategy was designed for maximum sensitivity using 
free text, thesaurus terms and exploded thesaurus terms. 
There were no language or time restrictions in the searches. 
Appendix 1 provides full details. Additionally, the refer-
ences of relevant studies were screened for eligible papers.
5. Data collection and analysis 
Two review authors (S.A., A.H.) independently reviewed 
the titles and abstracts identified from the search. Full-
text publications were obtained when necessary and 
eligibility was determined independently by the au-
thors. The authors independently extracted data from 
the studies fulfilling the inclusion criteria and assessed 
quality of included studies. The data was extracted us-
ing an agreed data extraction form. Where the incidence 
of PE or DVT was not directly reported in the included 
studies, it was calculated from the results. We adopted 
the Cochrane risk of bias tool for non-randomized tri-
als (ACROBAT-NRSI) to assess the quality of included 
studies [16]. The tool assesses domains of sequence 
generation, allocation concealment, confounding, out-
come measurement and assessment and follow-up. 
Results
A total of 4305 references were identified from the search. 
The search at the Cochrane Library, MEDLINE and 
EMBASE retrieved 145, 1,199, and 2,961 results, respec-
tively. After exclusion of duplicate articles, a total of 2,770 
references were left. After screening titles and abstracts, 
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172 papers were judged relevant. The full text of these 
was retrieved, and four additional relevant articles were 
identified from cross-referencing. Of these, 165 articles 
reported VTE in the acute phase of SCI or did not docu-
ment VTE timing. Seven studies reported PE in the sub-
acute phase as part of mortality investigation or only 
reported post-mortem PE diagnosed by autopsy. Those 
studies were thought to be of limited benefit in estimating 
PE incidence in living patients and so were not relevant to 
this review. Seven articles met the inclusion criteria (Fig. 
1). No randomized trials were identified. Included studies 
were retrospective case series or cohort studies. Charac-
teristics of the included studies are summarized in Table 1.
1. Quality assessment 
Risk of bias in the seven studies is summarized in Fig. 
2. No randomized controlled or quasi randomized trials 
were found. None of the included studies pre-specified a 
list of potential VTE confounders in the sub-acute phase. 
None of the studies involved statistical modelling for 
confounding factors. We could not tell from the included 
reports if confounding factors, such as infection, surgical 
intervention or lack of thromboprophylaxis, contributed 
to VTE incidence. Diagnosis of PE was based on perfu-
sion lung scan using 99m TC macro-aggregated albumin 
particle in one study [17] and using ventilation-perfusion 
scans and pulmonary angiography in another [18]. El 
Masri and Silver [19] diagnosed PEs clinically using the 
criterion of sudden onset of pleuritic chest pain lasting 
more than 12 hours with hemoptysis, after the exclusion 
of chest infection and a cardiac event. CTPA and perfu-
sion lung scan were used to diagnose PE in one study [20]. 
We could not tell how PE diagnosed by Chung et al. [21]. 
DVT was diagnosed in McKinley et al. [18] clinically or 
with 1–125 labelled fibrinogen uptake citation, impedance 
plethysmography, Doppler or venography. In Mackiewicz-
Mile et al. [22] DVT was diagnosed by D-dimer and ultra-
sound Doppler. Lamb et al. [23] accepted any diagnostic 
method for VTE for inclusion; however we could not 
tell how patients were diagnosed with PE or DVT from 
the report. The study reported total VTE events without 
distinguishing between PE and DVT in the final results. 
Methods for collecting data were poorly reported and we 
4,305 References 
identified
from databases
2,770 Records after
exclusion of 
duplicates
172 Full texts 
assessed for
eligibility
7 Papers met 
inclusion criteria
2,598 Excluded including 
case reports, reviews 
or not relevant to SCI 
or VTE
165 Excluded as not 
relevant i.e., acute 
phase of injury, mortality 
investigations or did not 
specify timing of  VTE
Fig. 1. Study flow diagram. SCI, spinal cord in jury; VTE, venous throm-
boembolism.
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Fig. 2. Risk of bias summary.
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could not tell if any of the studies used more than one out-
come assessor to repeat the analysis to ensure reliability. 
However, as PE and DVT were diagnosed using objective 
imaging methods the risk of bias in outcome assessment 
was thought to be low. In Alabed et al. [20] data about 
CTPA and perfusion scans were collected from Centricity 
Radiology Information Systems. Images were reported by 
different consultant radiologists. The included papers did 
not report incomplete or missing data. We could not tell if 
this was because of lack or reporting or absence of miss-
ing data. 
2. Pulmonary Embolism
Five papers reported PEs in the sub-acute phase. We did 
not pool data in a meta-analysis because of differences 
in populations, study designs and outcome reporting in 
the included studies. We reported the incidence of PE 
as reported by the included papers. However, where the 
included papers did not report the incidence of PE, we 
calculated it, if possible, from the reported findings. Per-
kash et al. [17] is a retrospective case series that reviewed 
50 spinal patients at the Veterans Administration Hospital, 
Palo Alto, California between 1976 and 1977. They report-
ed a total of 4 PEs, of which 3 were in the sub-acute phase. 
Two PEs in the sub-acute phase were recurrent episodes of 
thromboembolism. All PEs were confirmed on perfusion 
lung scan. The calculated PE incidence is 6%. El Masri 
and Silver [19] reported on a retrospective case series of 
102 consecutive patients admitted to the National Spinal 
Injuries Centre, Aylsebury, UK between 1976 and 1979. 
They reported 19 PEs, of which two were in the sub-acute 
phase. Both patients with PE had inadequate anticoagula-
tion (less than 6 weeks) and one had multiple PEs prior to 
the sub-acute PE. The calculated sub-acute PE incidence 
was 2%. McKinley et al. [18] described a multicenter retro-
spective case series. The data of 6,772 spinal patients were 
reviewed from the National Spinal Cord Injury Statistical 
Centre, Birmingham, AL, from 1973 to 1998. The diagno-
sis of PE reported in the database was made clinically or 
confirmed with ventilation-perfusion scans or pulmonary 
angiography. The study reported a PE incidence of 0.5% 
within the first year of SCI. We could not tell the sub-
acute PE incidence separately from the reported findings. 
Chung et al. [21] was a retrospective cohort study involv-
ing data retrieved from the National Health Insurance Re-
search Database of Taiwan from 1998 to 2008. The study 
included 47,916 spinal patients and 191,664 matched 
non-SCI controls. It reported a PE incidence of 4.76 per 
10,000-person-years in the sub-acute phase compared to 
1.48 per 10,000-person-years in the non-spinal patient 
group. Alabed et al. [20] described a retrospective case se-
ries of 640 spinal patients at the aforementioned National 
Spinal Injuries Centre. The study reviewed every CTPA or 
perfusion lung scan for all new admissions between 2008 
and 2013. The PE incidence in the sub-acute phase was 
1.25%; 95% confidence interval 0.39–2.11.
3. Deep venous thrombosis
Three studies reported on DVTs in the sub-acute phase. 
Lamb et al. [23] reported a retrospective case series that 
reviewed the medical charts of 287 spinal patients treated 
at the Spinal Cord Injury Centre, Zablocki Veteran’s Af-
fairs Medical Centre, Milwaukee, WI. VTE was counted 
if it was mentioned in the patient’s chart regardless of 
diagnostic method used. The study reported total VTE 
incidence without specifying if the event was a PE or 
DVT. Eleven patients had VTE events in the sub-acute 
phase. We could not tell if these events were DVTs or PEs 
or both. The VTE incidence was 5.9% in the acute phase 
and 3.8% in the sub-acute phase. McKinley et al. [18] re-
ported a DVT incidence rate of 2.1% in the first year post-
injury. We could not tell the sub-acute DVT incidence 
separately from the reported findings. In the third study, 
Mackiewicz-Milewska et al. [22] presented an abstract of 
a prospective case series that included 63 spinal patients 
from the rehabilitation department in Bydgoszcz, Poland. 
The study reported five DVTs in the sub-acute phase di-
agnosed with Doppler ultrasound. The DVT incidence in 
the sub-acute phase was 7.9%.
4. Thromboprophylaxis
The included studies poorly reported type, dose or du-
ration of anticoagulation used. In the study of El Masri 
and Silver [19], 66 of 102 patients received prophylactic 
anticoagulation with phenindione 25 to 100 mg daily for 
up to 3 months post-injury, and the remaining 36 patients 
were either admitted after 3 months post injury or had 
contraindications to anticoagulation. No patient diag-
nosed with PE was adequately anti-coagulated at the time 
of PE due to contraindications or interventions. Lamb et 
al. [23] did not use prophylactic anticoagulation. Prophy-
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lactic compression stockings and leg exercise were used. 
Perkash et al. [17] reported the use of prophylactic com-
pression stockings and leg exercise. We could not tell if 
prophylactic anticoagulation was used or not. In Alabed et 
al. [20], all patients received prophylactic anticoagulation 
with injections of low molecular weight heparin and use 
of compression stockings for up to 3 months post injury. 
We could not tell what type of thromboprophylaxis was 
used in McKinley et al. [18] or Chung et al. [21]. No study 
reported thromboprophylaxis beyond 90 days post SCI. 
Discussion
Seven studies reported PE and DVT events in the sub-
acute phase of SCI. The included studies were retrospec-
tive case series or cohort studies. The included studies 
reported a PE incidence of 0.5%–6.0% and a DVT inci-
dence of 2.0%–8.0% in the sub-acute phase of SCI. This 
is lower than the 6%–12% incidence in the acute phase of 
SCI [3,24]. However, the incidence of PE in the sub-acute 
phase of SCI remains significantly higher than that of the 
normal population (0.06%/year) [25,26].
Thromboprophylaxis methods used were poorly docu-
mented. It is not clear whether VTEs occurred due to 
absence of thromboprophylaxis, lack of compliance or 
if VTEs occurred despite thromboprophylaxis. Current 
practice is to give 3 months of anticoagulation post-injury. 
However, as the risk of VTE remains significant up to 6 
months post-injury, there is a need to investigate the ef-
ficacy of extending thromboprophylaxis to cover the sub-
acute injury period. Clinicians are advised to have a low 
threshold for suspecting VTE in the sub-acute phase of 
SCI.
Study Limitations
Studies were retrospective without a clear follow-up pe-
riod. Variations between studies did not permit a meta-
analysis to calculate an incidence rate for PE or DVT. 
Only one included study used CTPA to diagnose PE [20]. 
As CTPA is the current gold standard for diagnosing PE, 
incidence of PE might be higher than reported in the in-
cluded studies.
Two studies reported PE and DVT up to 12 months 
post-injury [18,21]. Both studies were included as they 
provided information about VTE events during the pe-
riod of interest. However, as they covered a period longer 
then the sub-acute phase, they may not accurately reflect 
the incidence of VTE in the sub-acute phase.
Conclusions
This review includes papers reporting PE and DVT events 
in the sub-acute phase of SCI when thromboprophylaxis 
is routinely stopped. This review highlights the fact that 
spinal patients continue to have a significant risk of PE 
and DVT after thromboprophylaxis is stopped in the sub-
acute phase of the injury. More evidence in the form of 
larger, well documented prospective cohort studies with 
follow-up is needed to determine exact VTE incidence 
rates. 
1. What is already known on this topic
The risk of VTE in acute spinal cord injury is one of the 
highest among patients’ groups. Current guidelines rec-
ommend 3 months thromboprophylaxis post injury.
2. What this study adds
There remains a significant risk of VTE in the sub-acute 
spinal injury period. However, a large prospective cohort 
studies is needed to establish the real risk of thrombo-
embolism in this period. Double-blind randomized con-
trolled trials are needed to establish the effect of extending 
thromboprophylaxis to cover the sub-acute injury period.
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Appendix 1. 
Search Strategies
MEDLINE database was searched via HDAS platform from 1950 to March 18th 2015 for relevant studies.
The search strategy has:
● Used both free text and thesaurus terms
● Exploded thesaurus terms to capture narrower terms
● Used the adjacency operator (adj)
● Not used subheadings as are rarely used at systematic reviews
● Not restricted to major focus as is rarely used at systematic reviews
1. MEDLINE  exp SPINAL CORD INJURIES/
2. MEDLINE  exp SPINAL FRACTURES/
3. MEDLINE  exp PARAPLEGIA/
4. MEDLINE  exp QUADRIPLEGIA/
5. MEDLINE  (paraplegi* OR paraparesis).ti,ab
6. MEDLINE  (quadriplegi* OR quadriparesi*).ti,ab
7. MEDLINE  (tetraplegia* OR tetraplagi* OR tetraparesis).ti,ab
8. MEDLINE  ((spine OR spinal) adj3 (broken OR break* OR fracture* OR wound* OR trauma* OR injur* 
OR damag*)).ti,ab
9. MEDLINE  ((spinal cord) adj3 (contusion OR laceration OR trauma OR injur* OR ischemi*)).ti,ab
10. MEDLINE  “central cord injury syndrome”.ti,ab
11. MEDLINE  (myelopathy adj3 (traumatic OR post-traumatic)).ti,ab
12. MEDLINE  exp CENTRAL CORD SYNDROME/
13. MEDLINE  exp SPINAL CORD ISCHEMIA/
14. MEDLINE  1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13
15. MEDLINE  THROMBOSIS/
16. MEDLINE  THROMBOEMBOLISM/
17. MEDLINE  exp VENOUS THROMBOSIS/
18. MEDLINE  exp PULMONARY EMBOLISM/
19. MEDLINE  EMBOLISM/
20. MEDLINE  VENOUS THROMBOEMBOLISM/
21. MEDLINE  (pulmonary adj2 (embolism* OR thromboembolism*)).ti,ab
22. MEDLINE  ((venous OR “deep venous” OR “deep-venous” OR “deep vein” OR “deep-vein”) adj2 thrombos*).ti,ab
23. MEDLINE  ((PE OR DVT OR VTE)).ti,ab
24. MEDLINE  (venous adj3 thromboemboli*).ti,ab
25. MEDLINE  15 OR 16 OR 17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24
26. MEDLINE  14 AND 25
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EMBASE database was searched via HDAS platform from 1980 to 18th March 2015 for relevant studies.
The search strategy has:
● Used both free text and thesaurus terms
● Exploded thesaurus terms to capture narrower terms
● Used the adjacency operator (adj)
● Not used subheadings as are rarely used at systematic reviews
● Not restricted to major focus as is rarely used at systematic reviews
 
27. EMBASE  exp SPINAL CORD INJURY/
28. EMBASE  exp SPINE FRACTURE/
29. EMBASE  exp PARAPLEGIA/
30. EMBASE  exp QUADRIPLEGIA/
31. EMBASE  (paraplegi* OR paraparesis).ti,ab
32. EMBASE  (quadriplegi* OR quadriparesi*).ti,ab
33. EMBASE  (tetraplegia* OR tetraplagi* OR tetraparesis).ti,ab
34. EMBASE  ((spine OR spinal) adj3 (broken OR break* OR fracture* OR wound* OR trauma* OR injur* 
OR damag*)).ti,ab
35. EMBASE  ((spinal cord) adj3 (contusion OR laceration OR trauma OR injur* OR ischemi*)).ti,ab
36. EMBASE  “central cord injury syndrome”.ti,ab
37. EMBASE  (myelopathy adj3 (traumatic OR post-traumatic)).ti,ab
38. EMBASE  exp CENTRAL CORD SYNDROME/
39. EMBASE  exp SPINAL CORD ISCHEMIA/
40. EMBASE  27 OR 28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38 OR 39
41. EMBASE  THROMBOSIS/
42. EMBASE  THROMBOEMBOLISM/
43. EMBASE  exp VEIN THROMBOSIS/
44. EMBASE  exp LUNG EMBOLISM/
45. EMBASE  EMBOLISM/
46. EMBASE  VENOUS THROMBOEMBOLISM/
47. EMBASE  (pulmonary adj2 (embolism* OR thromboembolism*)).ti,ab
48. EMBASE  ((venous OR “deep venous” OR “deep-venous” OR “deep vein” OR “deep-vein”) adj2 thrombos*).ti,ab
49. EMBASE  ((PE OR DVT OR VTE)).ti,ab
50. EMBASE  (venous adj3 thromboemboli*).ti,ab
51. EMBASE  41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47 OR 48 OR 49 OR 50
52. EMBASE  40 AND 51
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The 6 Cochrane Library databases were searched for relevant studies from the below periods:
● Cochrane Database of Systematic Reviews (CDSR) from 2005 to March 18th 2015
● Database of Abstracts of Reviews of Effects (DARE) from 1994 to March 18th 2015
● Cochrane Central Register of Controlled Trials (CENTRAL) from 1898 to March 18th 2015
● Cochrane Methodology Register from 1951 to March 18th 2015
● Health Technology Assessment Database from 1989 to March 18th 2015
● NHS Economic Evaluation Database from 1968 to March 18th 2015
#1  MeSH descriptor: [Spinal Cord Injuries] explode all trees
#2  MeSH descriptor: [Spinal Fractures] explode all trees
#3  MeSH descriptor: [Paraplegia] explode all trees
#4  MeSH descriptor: [Quadriplegia] explode all trees
#5  paraplegi* or paraparesis
#6  quadriplegi* or quadriparesi*
#7  tetraplegia* or tetraplagi* or tetraparesis
#8  (spine or spinal) near/3 (broken or break* or fracture* or wound* or trauma* or injur* or damag*)
#9  (spinal cord) near/3 (contusion or laceration or trauma or injur* or ischemi*)
#10  “central cord injury syndrome”
#11  myelopathy near/3 (traumatic or post traumatic)
#12  MeSH descriptor: [Central Cord Syndrome] explode all trees
#13  MeSH descriptor: [Spinal Cord Ischemia] explode all trees
#14  #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13
#15  MeSH descriptor: [Thrombosis] this term only
#16  MeSH descriptor: [Thromboembolism] this term only
#17  MeSH descriptor: [Venous Thrombosis] explode all trees
#18  MeSH descriptor: [Pulmonary Embolism] explode all trees
#19  MeSH descriptor: [Embolism] this term only
#20  MeSH descriptor: [Venous Thromboembolism] this term only
#21  pulmonary near/2 (embolism* or thromboembolism*)
#22  (venous or “deep venous” or “deep venous” or “deep vein” or “deep vein”) near/2 thrombos*
#23  PE or DVT or VTE
#24  venous near/3 thromboemboli*
#25  #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24
#26  #14 and #25
 
